ClinicalTrials.Veeva

Menu

The Use of the VOMS Tool With Military Personnel to Track mTBI Recovery and RTD Status

University of Pittsburgh logo

University of Pittsburgh

Status

Completed

Conditions

Mild Traumatic Brain Injury

Treatments

Diagnostic Test: Vestibular Ocular Motor Screening Tool (VOMS)

Study type

Interventional

Funder types

Other
Other U.S. Federal agency

Identifiers

NCT02634944
PRO15090054

Details and patient eligibility

About

The purpose of the proposed project is to determine if the VOMS is an effective screening tool to identify and track recovery of vestibular and ocular motor impairment and symptoms following mTBI, that corpsman-level medical personnel can successfully implement in combat and non-combat environments. A second purpose of the project is to determine if impairment and symptoms on the VOMS is more pronounced following blast compared to blunt mTBI.

Full description

Vestibular impairment and symptoms are prevalent following mild traumatic brain injury (mTBI) and may play a role in prolonged recovery. Researchers have indicated that ocular motor dysfunction and symptoms are common among personnel exposed to blast mTBI. In fact, researchers have suggested that vestibular and ocular motor outcomes such as VOR and vestibulo-spinal reflex (VSR) may be useful in identifying the effects of blast from blunt mTBI. There are currently no brief, clinical screening tools to identify vestibular/ocular motor impairment and symptoms in military personnel following mTBI. Our research team recently developed the Vestibular/Ocular Motor Screening (VOMS) tool to screen for vestibular/ocular motor impairment and symptoms following mTBI. Our preliminary research indicates that VOMS- a 5-min clinical screening tool that can be deployed by corpsman-level (i.e., Special Operation Combat Medics [SOCM], Special Forces Medical Sergeants [18D]) medical personnel with minimal training and materials- was nearly 90% accurate in identifying patients with mTBI from healthy controls. These preliminary findings suggest that VOMS may augment current clinical screening tools- such as the MACE- used by the U.S. Military. The proposed project addresses the "studies to develop standardized metrics for vestibular assessment and monitoring for return to duty" area in the Diagnostics subsection of the Hearing Loss/Dysfunction, Balance Disorder, and or Tinnitus section under the Clinical Trial Research Focus Area.

Enrollment

452 patients

Sex

All

Ages

18 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • All Participants:

    • Military personnel;
    • Age 18-40 years;
    • Normal or corrected normal vision
  • mTBI Participants:

    • Diagnosed with mTBI (blast, blunt, or combo) within past 7 days
    • Clear mechanism of injury
    • Glasgow Coma Scale (GCS) = 13-15
    • Reported or observed signs (Loss of consciousness [LOC], amnesia, disorientation/confusion) at time of injury
    • Current reported symptoms and/or impairment (cognitive, balance, visual)

Exclusion criteria

  • History of vestibular disorder;
  • History of neurological disorder;
  • History of previous moderate to severe TBI

Trial design

Primary purpose

Screening

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

452 participants in 4 patient groups

mTBI
Experimental group
Description:
mTBI (concussed) participants will be administered the VOMS after concussive event. The VOMS- which requires only a small target with 14 point font text and takes only 5 min to administer- includes assessments in five domains: (1) smooth pursuits, (2) horizontal and vertical saccades, (3) near point of convergence (NPC) distance, (4) horizontal and vertical VOR, and (5) VMS.
Treatment:
Diagnostic Test: Vestibular Ocular Motor Screening Tool (VOMS)
Healthy Control
Sham Comparator group
Description:
Healthy controls will be administered the VOMS tool. The VOMS- which requires only a small target with 14 point font text and takes only 5 min to administer- includes assessments in five domains: (1) smooth pursuits, (2) horizontal and vertical saccades, (3) near point of convergence (NPC) distance, (4) horizontal and vertical VOR, and (5) VMS.
Treatment:
Diagnostic Test: Vestibular Ocular Motor Screening Tool (VOMS)
BLAST mTBI
Experimental group
Description:
Blast mTBI (concussed) participants will be administered the VOMS after concussive blast event. The VOMS- which requires only a small target with 14 point font text and takes only 5 min to administer- includes assessments in five domains: (1) smooth pursuits, (2) horizontal and vertical saccades, (3) near point of convergence (NPC) distance, (4) horizontal and vertical VOR, and (5) VMS.
Treatment:
Diagnostic Test: Vestibular Ocular Motor Screening Tool (VOMS)
BLUNT mTBI
Experimental group
Description:
Blunt mTBI (concussed) participants will be administered the VOMS after concussive blunt event. The VOMS- which requires only a small target with 14 point font text and takes only 5 min to administer- includes assessments in five domains: (1) smooth pursuits, (2) horizontal and vertical saccades, (3) near point of convergence (NPC) distance, (4) horizontal and vertical VOR, and (5) VMS.
Treatment:
Diagnostic Test: Vestibular Ocular Motor Screening Tool (VOMS)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems